SCHEMBL231898

SCHEMBL231898

CC[N+](C)(C)CCOC.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29904694 0.90 BBOX1 (0.39) BBOX1
SCHEMBL1535099 0.87 CHRM2 (0.30)
SCHEMBL31651500 0.82 BBOX1 (0.37) BBOX1
SCHEMBL29904613 0.81 BBOX1 (0.36) BBOX1
SCHEMBL29444882 0.80 SLC22A1 (0.33)
SCHEMBL29395684 0.79 DNM1 (0.45) BBOX1
SCHEMBL29396934 0.78 DNM1 (0.53) BBOX1
SCHEMBL30596363 0.78
SCHEMBL31049447 0.77 BBOX1 (0.32) BBOX1
SCHEMBL31121681 0.77 DNM1 (0.57) BBOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110607-A1 VARIABLE EMISSIVITY SURFACES The University of Manchester (GB) 2023-01-04 EP claimed
EP-4690341-A1 ELECTROLYTE SYSTEM OXLiD Ltd (GB) 2026-02-11 EP disclosed
WO-2024223586-A1 DEVICE, METHOD AND COMPUTER PROGRAM FOR PROCESSING OF A SURFACE OF A SUBSTRATE CARL ZEISS SMT GMBH (DE) 2024-10-31 WO disclosed
WO-2024201348-A1 ELECTROLYTE SYSTEM OXLID LTD (GB) 2024-10-03 WO disclosed
US-20230420647-A1 LITHIUM-SELENIUM CELL JOHNSON MATTHEY PLC (GB) 2023-12-28 US disclosed
WO-2023105202-A1 ELECTROCHEMICAL CELL OXLID LTD (GB) 2023-06-15 WO disclosed
EP-4162548-A1 ELECTROCHEMICAL CELL Johnson Matthey Public Limited Company (GB) 2023-04-12 EP disclosed
WO-2022210912-A1 AMMONIA PRODUCTION METHOD AND AMMONIA PRODUCTION APPARATUS 国立大学法人東京大学 2022-10-06 WO disclosed
WO-2022210925-A1 METHOD FOR REGENERATING CATALYST IN DEVICE FOR PRODUCING AMMONIA 国立大学法人東京大学 2022-10-06 WO disclosed
US-9580772-B2 Electrorecovery of metals COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2017-02-28 US disclosed
EP-2408950-A1 ELECTRORECOVERY OF METALS Commonwealth Scientific and Industrial Research Organisation (AU) 2012-01-25 EP disclosed
US-20120000790-A1 ELECTRORECOVERY OF METALS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2012-01-05 US disclosed
WO-2010105299-A1 ELECTRORECOVERY OF METALS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120000790-A1 ELECTRORECOVERY OF METALS SLC6A9, SLC39A14, SLC8A1 BBOX1 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.